The taboo associated with psychedelic use is waning. Worldwide ketamine and esketamine (Spravato), are being used more frequently in various therapeutic contexts. This shift is part of a larger trend in recognizing the potential benefits of psychedelics, which were once dismissed due to stigma and legal restrictions. Research has been burgeoning in this field, exploring the therapeutic potential of these substances in treating conditions like depression, PTSD, and anxiety.

The increased interest in psychedelics is not just in the medical community; there’s a growing public curiosity and acceptance. This change reflects a broader cultural shift towards exploring consciousness and exploring the different aspects of the psyche. However, it’s important to approach this topic with careful consideration of the legal, ethical, and health implications involved in using these substances.

More recently, Australia has become the first country in the world to recognise psilocybin and MDMA as legal prescribable medicines however, access is very restricted.

Psychedelic Health Tourism

The legal acquisition of psychedelics is a complex issue, as it varies widely from country to country. Some regions of the world have decriminalized or legalized certain psychedelics for medical or therapeutic use, while others maintain strict regulations or criminalize their possession. It is essential for individuals to research and understand the legal framework and regulations surrounding psychedelics in their respective jurisdictions (see map below) to ensure safe and responsible use.

Many of these legal jurisdictions have become hosts to a range of varying quality retreats which offer medicine and integration to patients. Below is a map of legal retreats around the world, if you are interested in attending one of these retreats, get in contact, as this site maintains a quality-controlled list.